The previous study proved that IL‐6 localized in endometrial cancer cells and promoted cancer progression via a paracrine manner and demonstrated that IL‐6 activation was associated with endometrial cancer development by inducing aromatase expression in intratumoral stromal cells (Che, Liu, Liao et al., 2014). The gene discussed is CYP19A1; the disease is cancer.